# fastGxE: Powering genome-wide detection of genotype-environment interactions in biobank studies

**Authors:** Chao Ning, Xiang Zhou

PMC · DOI: 10.21203/rs.3.rs-5952773/v1 · 2025-03-20

## TL;DR

fastGxE is a fast and scalable method for detecting gene-environment interactions in large biobank studies, revealing new genetic loci linked to physical traits and blood biomarkers.

## Contribution

fastGxE introduces a scalable and efficient genome-wide method for detecting GxE interactions with improved speed and accuracy.

## Key findings

- fastGxE achieves 32.98–126.49 times speed improvements over existing GxE methods.
- fastGxE identifies nine genomic loci for physical traits, six of which are novel.
- fastGxE uncovers 26 genomic loci for blood biomarkers, 19 of which are novel.

## Abstract

Traditional genome-wide association studies (GWAS) have primarily focused on detecting main genotype effects, often overlooking genotype-environment interactions (GxE), which are essential for understanding context-specific genetic effects and refining disease etiology. Here, we present fastGxE, a scalable and effective genome-wide GxE method designed to identify genetic variants that interact with environmental factors to influence traits of interest. fastGxE controls for both polygenic effects and polygenic interaction effects, is robust to the number of environmental factors involved in GxE interactions, and ensures scalability for genome-wide GxE analysis in large biobank studies, achieving speed improvements of 32.98–126.49 times over existing approaches. We illustrate the benefits of fastGxE through extensive simulations and an in-depth analysis of 32 physical traits and 67 blood biomarkers from the UK Biobank. In real data applications, fastGxE identifies nine genomic loci associated with physical traits, including six novel ones, and 26 genomic loci associated with blood biomarkers, 19 of which are novel. The new discoveries highlight the dynamic interplay between genetics and the environment, uncovering potentially clinically significant pathways that could inform personalized interventions and treatment strategies.

## Full-text entities

- **Genes:** CHRNB4 (cholinergic receptor nicotinic beta 4 subunit) [NCBI Gene 1143], RSPO3 (R-spondin 3) [NCBI Gene 84870] {aka CRISTIN1, PWTSR, THSD2}, IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 3486] {aka BP-53, IBP-3, IBP3, IGFBP-3}, LIPA (lipase A, lysosomal acid type) [NCBI Gene 3988] {aka CESD, LAL}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, ULK4 (unc-51 like kinase 4) [NCBI Gene 54986] {aka FAM7C1, REC01035}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, HYKK (hydroxylysine kinase) [NCBI Gene 123688] {aka AGPHD1}, FBXO32 (F-box protein 32) [NCBI Gene 114907] {aka Fbx32, MAFbx}, Tnfrsf11b (tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)) [NCBI Gene 18383] {aka OCIF, Opg, TR1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, Cobll1 (Cobl-like 1) [NCBI Gene 319876] {aka 1810047P18Rik, Coblr1, D430044D16Rik}, LYPLAL1-DT (LYPLAL1 divergent transcript) [NCBI Gene 643723] {aka LYPLAL1-AS1}, UGT1A1 (UDP glucuronosyltransferase family 1 member A1) [NCBI Gene 54658] {aka BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT 1-1, UGT1}, CHRNA3 (cholinergic receptor nicotinic alpha 3 subunit) [NCBI Gene 1136] {aka BAIPRCK, LNCR2, NACHRA3, PAOD2}, Wnt16 (wingless-type MMTV integration site family, member 16) [NCBI Gene 93735] {aka E130309I19Rik}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, CHRNA5 (cholinergic receptor nicotinic alpha 5 subunit) [NCBI Gene 1138] {aka LNCR2}, FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068] {aka ALKBH9, BMIQ14, GDFD, IFEX9}, IRX3 (iroquois homeobox 3) [NCBI Gene 79191] {aka IRX-1, IRXB1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ARHGEF3 (Rho guanine nucleotide exchange factor 3) [NCBI Gene 50650] {aka GEF3, STA3, XPLN}
- **Diseases:** obesity (MESH:D009765), BMI (MESH:C536030), type B aortic dissection (MESH:D000784), lipid metabolism abnormalities (MESH:D052439), impaired glucose tolerance (MESH:D018149), addiction (MESH:D019966), PP (MESH:D003668), dilated cardiomyopathy (MESH:D002311), sleeplessness (MESH:D007319), fracture (MESH:D050723), hypertension (MESH:D006973), BMD (MESH:D001851), metabolic diseases (MESH:D008659), muscle atrophy (MESH:D009133)
- **Chemicals:** cholesterol (MESH:D002784), lipids (MESH:D008055), TC (-), nitric oxide (MESH:D009569), salt (MESH:D012492), Bilirubin (MESH:D001663), TG (MESH:D014280), Alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** rs8063057, rs12149574, rs113572208, rs6717858, rs964184, rs6712203, rs3174744, rs2244608, rs10939663, rs7651190, rs55662831, rs1938498, rs3778217, rs62203749, rs769449, rs887829, rs73015024, rs8107974, rs138529890, rs9928757, rs62201973, rs3091244, rs58542926, rs56196860, rs72941885, rs6952851, rs12694211, rs55872725, rs4697948, rs6674544, rs79639185, rs6938647, rs858519, rs10254825, rs2003757, rs7696983, rs3767145, rs4461524, rs13333226, rs577721086, rs28640218, rs8042849, rs319737, rs118039278, rs1047891, rs7528419, rs80215559, rs12944954, rs56077333, rs55953331, rs13389219, rs10766194, rs3747207, rs62033400, rs116970203, rs2908007, rs1042522, rs34601425, rs6847871, rs1510224

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11957207/full.md

---
Source: https://tomesphere.com/paper/PMC11957207